Fingerprint
Dive into the research topics of 'The efficacy and safety of insulin degludec given in variable once-daily dosing intervals compared with insulin glargine and insulin degludec dosed at the same time daily: A 26-week, randomized, open-label, parallel-group, treat-to-target trial in individuals with type 2 diabetes'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically